77401495 - GLENMARK GENERICS LTD.

Information

• Trademark
• 77401495

• Source

• Serial Number

  77401495

• Registration Number

  3998467

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  February 20, 2008
  16 years ago

• Registration Date

  July 19, 2011
  13 years ago

• Transaction Date

  March 01, 2022
  2 years ago

• Status Date

  January 21, 2022
  3 years ago

• Published for Opposition Date

  January 27, 2009
  16 years ago

• Location Date

  September 02, 2017
  7 years ago

• First Use Anywhere Date

  April 01, 2008
  16 years ago

• First Use In Commerce Date

  April 01, 2008
  16 years ago

• Status Code

  710

• Current Location

  TMEG LAW OFFICE 109

  Employee Name

  WATSON, JULIE A

• Attorney Docket Number

  GGL

  Attorney Name

  Hany W. Rizkalla

  Law Office Assigned Location Code

  L90

• Owners

  • GLENMARK GENERICS INC., USA
  • Glenmark Pharmaceuticals Inc., USA

Case File Statements

• GS0051: Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Preparation for the relief of pain
• PM0001: GLEN MARK GENERICS LTD.
• D10000: "GENERICS LTD."

Case File Event Statements

• 1/21/2022 - 3 years ago

  60 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Type: CAEX

• 7/19/2020 - 4 years ago

  59 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 9/2/2017 - 7 years ago

  58 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8

• 9/2/2017 - 7 years ago

  57 - REGISTERED - SEC. 8 (6-YR) ACCEPTED Type: 8.OK

• 8/23/2017 - 7 years ago

  56 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 7/14/2017 - 7 years ago

  55 - TEAS SECTION 8 RECEIVED Type: ES8R

• 7/19/2011 - 13 years ago

  54 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/16/2011 - 13 years ago

  53 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 6/15/2011 - 13 years ago

  52 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV

• 6/10/2011 - 13 years ago

  51 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 6/10/2011 - 13 years ago

  50 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/9/2011 - 13 years ago

  49 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 6/7/2011 - 13 years ago

  48 - USE AMENDMENT FILED Type: IUAF

• 6/9/2011 - 13 years ago

  47 - EXTENSION 4 GRANTED Type: EX4G

• 4/21/2011 - 13 years ago

  46 - EXTENSION 4 FILED Type: EXT4

• 6/7/2011 - 13 years ago

  45 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 6/7/2011 - 13 years ago

  44 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 6/7/2011 - 13 years ago

  43 - PETITION TO REVIVE-GRANTED Type: PETG

• 6/7/2011 - 13 years ago

  42 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 5/23/2011 - 13 years ago

  41 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/23/2011 - 13 years ago

  40 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/28/2010 - 14 years ago

  39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/27/2010 - 14 years ago

  38 - EXTENSION 3 GRANTED Type: EX3G

• 10/21/2010 - 14 years ago

  37 - EXTENSION 3 FILED Type: EXT3

• 10/26/2010 - 14 years ago

  36 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 10/26/2010 - 14 years ago

  35 - PETITION TO REVIVE-GRANTED Type: PETG

• 10/26/2010 - 14 years ago

  34 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 5/21/2010 - 14 years ago

  33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/20/2010 - 14 years ago

  32 - EXTENSION 2 GRANTED Type: EX2G

• 4/21/2010 - 14 years ago

  31 - EXTENSION 2 FILED Type: EXT2

• 5/19/2010 - 14 years ago

  30 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 5/19/2010 - 14 years ago

  29 - PETITION TO REVIVE-GRANTED Type: PETG

• 5/19/2010 - 14 years ago

  28 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 3/1/2010 - 14 years ago

  27 - EXTENSION 1 GRANTED Type: EX1G

• 10/21/2009 - 15 years ago

  26 - EXTENSION 1 FILED Type: EXT1

• 2/24/2010 - 14 years ago

  25 - PETITION GRANTED - EXTENSION REQUEST FILED Type: PGEX

• 2/3/2010 - 15 years ago

  24 - INCOMPLETE PETITION NOTICE MAILED Type: PINM

• 2/2/2010 - 15 years ago

  23 - ASSIGNED TO PETITION STAFF Type: APET

• 12/1/2009 - 15 years ago

  22 - PETITION TO REVIVE-RECEIVED Type: PETR

• 2/1/2010 - 15 years ago

  21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 12/1/2009 - 15 years ago

  20 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 12/1/2009 - 15 years ago

  19 - PETITION TO REVIVE-GRANTED Type: PETG

• 12/1/2009 - 15 years ago

  18 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 11/23/2009 - 15 years ago

  17 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 11/23/2009 - 15 years ago

  16 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 4/21/2009 - 15 years ago

  15 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/27/2009 - 16 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/7/2009 - 16 years ago

  13 - NOTICE OF PUBLICATION Type: NPUB

• 12/22/2008 - 16 years ago

  12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 12/16/2008 - 16 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/15/2008 - 16 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/15/2008 - 16 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/15/2008 - 16 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 12/1/2008 - 16 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/2/2008 - 16 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/2/2008 - 16 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/2/2008 - 16 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/2/2008 - 16 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/27/2008 - 16 years ago

  2 - NOTICE OF PSEUDO MARK MAILED Type: MPMK

• 2/26/2008 - 16 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP